Lupus drug in breast milk: new study seeks answers for nursing moms
NCT ID NCT06594068
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study is for mothers with lupus who are already taking the medication anifrolumab and are breastfeeding or pumping. Researchers will measure how much of the drug passes into breast milk and into the baby's blood. The goal is to better understand the safety of anifrolumab during breastfeeding. No new treatments are given—only observation and sample collection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGLas Vegas, Nevada, 89113, United States
Conditions
Explore the condition pages connected to this study.